Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
Top Cited Papers
- 23 August 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 376 (9744) , 895-902
- https://doi.org/10.1016/s0140-6736(10)61030-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hepatitis E Epidemic, UgandaEmerging Infectious Diseases, 2010
- Hepatitis E Outbreak on Cruise ShipEmerging Infectious Diseases, 2009
- Hepatitis E: an emerging infection in developed countriesThe Lancet Infectious Diseases, 2008
- Hepatitis E: An emerging awareness of an old diseasePublished by Elsevier ,2008
- Seroprevalence of Hepatitis E Virus Infection, Rural Southern People’s Republic of ChinaEmerging Infectious Diseases, 2006
- A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primatesVaccine, 2005
- Hepatitis E VaccinesDrugs, 2004
- Evaluation of antibody‐based and nucleic acid‐based assays for diagnosis of hepatitis E virus infection in a rhesus monkey modelJournal of Medical Virology, 2003
- Hepatitis E virus superinfection in patients with chronic liver diseaseHepatology, 2002
- Exact power and sample size for vaccine efficacy studiesCommunications in Statistics - Theory and Methods, 1998